767 related articles for article (PubMed ID: 29237922)
1. Outcomes of Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention in Patients Aged 18-45 Years with Diabetes Mellitus.
Li Y; Dong R; Hua K; Liu TS; Zhou SY; Zhou N; Zhang HJ
Chin Med J (Engl); 2017 Dec; 130(24):2906-2915. PubMed ID: 29237922
[TBL] [Abstract][Full Text] [Related]
2. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
[No Abstract] [Full Text] [Related]
3. Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial.
Dangas GD; Farkouh ME; Sleeper LA; Yang M; Schoos MM; Macaya C; Abizaid A; Buller CE; Devlin G; Rodriguez AE; Lansky AJ; Siami FS; Domanski M; Fuster V;
J Am Coll Cardiol; 2014 Sep; 64(12):1189-97. PubMed ID: 25236509
[TBL] [Abstract][Full Text] [Related]
4. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
[TBL] [Abstract][Full Text] [Related]
5. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
[TBL] [Abstract][Full Text] [Related]
6. Improved long-term survival for diabetic patients with surgical versus interventional revascularization.
Kurlansky P; Herbert M; Prince S; Mack MJ
Ann Thorac Surg; 2015 Apr; 99(4):1298-305. PubMed ID: 25686668
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Five-Year Outcome of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Triple-Vessel Coronary Artery Disease (from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2).
Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Tazaki J; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
Am J Cardiol; 2015 Jul; 116(1):59-65. PubMed ID: 25956622
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 30-day and 5-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients aged≤50 years (the Coronary aRtery diseAse in younG adultS Study).
Biancari F; Gudbjartsson T; Heikkinen J; Anttila V; Mäkikallio T; Jeppsson A; Thimour-Bergström L; Mignosa C; Rubino AS; Kuttila K; Gunn J; Wistbacka JO; Teittinen K; Korpilahti K; Onorati F; Faggian G; Vinco G; Vassanelli C; Ribichini F; Juvonen T; Axelsson TA; Sigurdsson AF; Karjalainen PP; Mennander A; Kajander O; Eskola M; Ilveskoski E; D'Oria V; De Feo M; Kiviniemi T; Airaksinen KE
Am J Cardiol; 2014 Jul; 114(2):198-205. PubMed ID: 24878127
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Coronary Artery Bypass Grafting and Drug-Eluting Stent Implantation in Patients With Chronic Kidney Disease: A Propensity Score Matching Study.
Li Y; Hou X; Liu T; Xu S; Huang Z; Xu X; Dong R
Front Cardiovasc Med; 2022; 9():802181. PubMed ID: 35433853
[TBL] [Abstract][Full Text] [Related]
10. [Long-term outcomes of patients with unprotected left main coronary artery disease post revascularization].
Yu X; Lyu S; He J; Gao Y; Luo Y; Song X; Yuan F; Huang F; Gu C; Chen F
Zhonghua Xin Xue Guan Bing Za Zhi; 2015 May; 43(5):399-403. PubMed ID: 26419983
[TBL] [Abstract][Full Text] [Related]
11. Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
J Am Coll Cardiol; 2015 Sep; 66(11):1209-1220. PubMed ID: 26361150
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes and comparison after conventional coronary artery bypass grafting for left main disease between patients classified as percutaneous coronary intervention recommendation classes II and III.
Cho Y; Misumi T; Shimura S; Aki A; Furuya H; Odagiri S; Okada K; Ueda T
Eur J Cardiothorac Surg; 2014 Mar; 45(3):431-7. PubMed ID: 23979988
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Disease.
Tam DY; Dharma C; Rocha R; Farkouh ME; Abdel-Qadir H; Sun LY; Wijeysundera HC; Austin PC; Udell JA; Gaudino M; Fremes SE; Lee DS
J Am Coll Cardiol; 2020 Sep; 76(10):1153-1164. PubMed ID: 32883408
[TBL] [Abstract][Full Text] [Related]
15. Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patients with diabetes mellitus: can newer generation drug-eluting stents bridge the gap?
Bangalore S; Toklu B; Feit F
Circ Cardiovasc Interv; 2014 Aug; 7(4):518-25. PubMed ID: 24939927
[TBL] [Abstract][Full Text] [Related]
16. CABG Versus PCI: Greater Benefit in Long-Term Outcomes With Multiple Arterial Bypass Grafting.
Habib RH; Dimitrova KR; Badour SA; Yammine MB; El-Hage-Sleiman AK; Hoffman DM; Geller CM; Schwann TA; Tranbaugh RF
J Am Coll Cardiol; 2015 Sep; 66(13):1417-27. PubMed ID: 26403338
[TBL] [Abstract][Full Text] [Related]
17. SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in the FREEDOM Trial.
Esper RB; Farkouh ME; Ribeiro EE; Hueb W; Domanski M; Hamza TH; Siami FS; Godoy LC; Mathew V; French J; Fuster V
J Am Coll Cardiol; 2018 Dec; 72(23 Pt A):2826-2837. PubMed ID: 30522646
[TBL] [Abstract][Full Text] [Related]
18. The impact of chronic kidney disease on outcomes following percutaneous coronary intervention versus coronary artery bypass grafting in patients with complex coronary artery disease: five-year follow-up of the SYNTAX trial.
Milojevic M; Head SJ; Mack MJ; Mohr FW; Morice MC; Dawkins KD; Holmes DR; Serruys PW; Kappetein AP
EuroIntervention; 2018 May; 14(1):102-111. PubMed ID: 29155387
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
[TBL] [Abstract][Full Text] [Related]
20. Everolimus-eluting stents or bypass surgery for multivessel coronary disease.
Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
N Engl J Med; 2015 Mar; 372(13):1213-22. PubMed ID: 25775087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
